Lack of association between serum magnesium and the risks of hypertension and cardiovascular disease.

Khan AM, Sullivan L, McCabe E, Levy D, Vasan RS, Wang TJ
Am Heart J. 2010 160 (4): 715-20

PMID: 20934566 · PMCID: PMC2953800 · DOI:10.1016/j.ahj.2010.06.036

BACKGROUND - Experimental studies have linked hypomagnesemia with the development of vascular dysfunction, hypertension, and atherosclerosis. Prior clinical studies have yielded conflicting results but were limited by the use of self-reported magnesium intake or short follow-up periods.

METHODS - We examined the relationship between serum magnesium concentration and incident hypertension, cardiovascular disease (CVD), and mortality in 3,531 middle-aged adult participants in the Framingham Heart Study offspring cohort. Analyses were performed using Cox proportional hazards regressions, adjusted for traditional CVD risk factors.

RESULTS - Follow-up was 8 years for new-onset hypertension (551 events) and 20 years for CVD (554 events). There was no association between baseline serum magnesium and the development of hypertension (multivariable-adjusted hazards ratio per 0.15 mg/dL 1.03, 95% CI 0.92-1.15, P = .61), CVD (0.83, 95% CI 0.49-1.40, P = .49), or all-cause mortality (0.77, 95% CI 0.41-1.45, P = .42). Similar findings were observed in categorical analyses, in which serum magnesium was modeled in categories (<1.5, 1.5-2.2, >2.2 mg/dL) or in quartiles.

CONCLUSIONS - In conclusion, data from this large, community-based cohort do not support the hypothesis that low serum magnesium is a risk factor for developing hypertension or CVD.

Copyright © 2010 Mosby, Inc. All rights reserved.

MeSH Terms (19)

Adult Blood Pressure Cardiovascular Diseases Cause of Death Colorimetry Female Follow-Up Studies Heart Diseases Humans Hypertension Incidence Magnesium Male Prognosis Retrospective Studies Risk Factors Survival Rate Time Factors United States

Connections (1)

This publication is referenced by other Labnodes entities: